These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 6085183

  • 1. [Immunochemical measurement of prostatic acid phosphatase in carcinoma of the prostate].
    Cooper EH, Bauer HW, Dati F.
    Ric Clin Lab; 1984; 14 Suppl 2():39-55. PubMed ID: 6085183
    [No Abstract] [Full Text] [Related]

  • 2. [Significance of an immunoenzyme assay of the prostate-specific acid phosphatase (PAP) (E.C.3.1.3.2.) in prostatic carcinoma. Methods and initial clinical results].
    Bauer HW, Schmiedt E.
    Urologe A; 1983 Sep; 22 Suppl():367-71. PubMed ID: 6195796
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical evaluation and measurement of plasma prostatic acid phosphatase by solid phase enzyme immunoassay].
    Okabe H, Noma A, Nakauchi K, Mori M.
    Rinsho Byori; 1986 Jul; 34(7):805-10. PubMed ID: 2428995
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prostatic acid phosphatase and prostate-specific antigen in prostate cancer.
    Kuriyama M, Loor R, Wang MC, Lee C, Killian CS, Papsidero LD, Inaji H, Nishiura T, Slack NH, Murphy GP, Chu TM.
    Int Adv Surg Oncol; 1982 Jul; 5():29-49. PubMed ID: 6178696
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Value of commercial enzyme immunoassays in the determination of prostatic acid phosphatase].
    Rassweiler J, Lutz K, Müller HA, Eisenberger F.
    Urologe A; 1988 Jan; 27(1):32-5. PubMed ID: 2452506
    [Abstract] [Full Text] [Related]

  • 12. [Prostatic acid phosphatase by enzymeimmunoassay].
    Masukagami T, Ando K, Shimazaki J.
    Hinyokika Kiyo; 1984 Nov; 30(11):1691-5. PubMed ID: 6084950
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The radioimmunochemical measurement of prostatic acid phosphatase: current state of the art.
    Cooper JF.
    Urol Clin North Am; 1980 Oct; 7(3):653-65. PubMed ID: 6161460
    [Abstract] [Full Text] [Related]

  • 19. A new fluorescent immunoassay for human prostatic acid phosphatase in prostate cancer (SPIF).
    Wajsman Z, Lee CL, Chu TM, Murphy GP.
    Surg Forum; 1979 Oct; 30():568-9. PubMed ID: 395710
    [No Abstract] [Full Text] [Related]

  • 20. What clinical information is wanted from measurements of tumor markers in carcinoma of the prostate?
    Andersson L.
    Scand J Clin Lab Invest Suppl; 1985 Oct; 179():107-14. PubMed ID: 3866303
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.